Predicting Which Cancer Cells May Become Drug-Resistant with Yogesh Goyal, PhD

Predicting Which Cancer Cells May Become Drug-Resistant with Yogesh Goyal, PhD

Author: Northwestern University Feinberg School of Medicine July 19, 2023 Duration: 20:58

Treating cancer has become increasingly difficult as cells develop resistance. Northwestern investigators have sought to address this issue on the cellular level through the development of a novel FateMap tool, used to predict the future behavior of cancer cells before they are exposed to cancer-fighting drugs. In this episode, Yogesh Goyal, PhD, discusses his latest research, published in Natureand how his lab is addressing complex problems through an interdisciplinary approach. 


Tune into Breakthroughs for a direct line to the labs and minds at Northwestern University Feinberg School of Medicine. Each episode pulls back the curtain on the process of discovery, letting you hear directly from the researchers themselves as they explain the questions that keep them up at night and the moments of insight that change everything. This isn't just about announcing findings; it's about understanding the human effort behind them. You'll get a clear sense of how a single study can ripple out, influencing treatments and shifting our entire approach to wellness. The conversations in this podcast are grounded in the belief that transforming medicine starts with asking better questions. From detailed explorations of cellular mechanisms to broader discussions on public health, the content connects the dots between specialized science and its real-world impact. Listen for thoughtful dialogue that makes complex topics accessible, always pointing toward a future where health is improved for entire communities. Produced by Northwestern University Feinberg School of Medicine, this series is for anyone curious about the tangible steps science is taking right now to create a healthier tomorrow.
Author: Language: English Episodes: 100

Breakthroughs
Podcast Episodes
Pursuing Precision Medicine for Rare Diseases with Gemma Carvill, PhD [not-audio_url] [/not-audio_url]

Duration: 26:10
Scientists from Northwestern Medicine, the Broad Institute of MIT and Harvard have uncovered the first rare genetic disorder linked to a long non-coding RNA gene. In this episode, Gemma Carvill, PhD, explains how this di…
Emerging Drug Targets in Parkinson's Disease with Joe Mazzulli, PhD [not-audio_url] [/not-audio_url]

Duration: 28:08
Nearly one million people in the U.S. are living with Parkinson's disease, a condition for which there is still no known cause or cure. Joseph Mazzulli, PhD, has led two recent studies published in Neuron and Nature Comm…
New Insights into Cellular Metabolism with Issam Ben-Sahra, PhD [not-audio_url] [/not-audio_url]

Duration: 18:14
New research from the lab of Issam Ben-Sahra, PhD, could rewrite textbooks on our understanding of cellular metabolism and potentially identify new targets for cancer and metabolic diseases such as obesity. The discovery…
Understanding Gut Microbiome Science with Jeffrey Gordon, MD [not-audio_url] [/not-audio_url]

Duration: 35:30
Jeffrey Gordon, MD, often called "the father of microbiome research," is the 2024 recipient of the Mechthild Esser Nemmers Prize in Medical Science. In this episode, Gordon discusses the impacts of his long career in gut…
How to Measure Biological Age with John Wilkins, MD [not-audio_url] [/not-audio_url]

Duration: 21:27
A team of Northwestern Medicine scientists are conducting a new longitudinal cross-sectional study to investigate why some people see to age faster than others. In this episode, John Wilkins, MD, associate director of th…